Sansure Biotech Inc Free Cash Flow Generation Index
Sansure Biotech Inc free cash flow generation index. Sansure Biotech Inc (688289) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-3.36 Million represents 0% of operating cash flow (CN¥59.72 Million). Check Sansure Biotech Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sansure Biotech Inc (2018–2025)
Free cash flow generation index of Sansure Biotech Inc from 2018 to 2025. Historical FCF Generation Index trend for Sansure Biotech Inc across 8 annual periods. Explore Sansure Biotech Inc (688289) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Sansure Biotech Inc Free Cash Flow Generation Index by Year (2018–2025)
Sansure Biotech Inc free cash flow generation index by year from 2018 to 2025. Year-by-year Free Cash Flow Generation Index for Sansure Biotech Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Sansure Biotech Inc.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | CN¥-185.81 Million | CN¥183.96 Million | CN¥369.77 Million | ▼ -89.0% |
| 2024 | -0.53x | CN¥-146.66 Million | CN¥274.45 Million | CN¥421.10 Million | ▲ +82.7% |
| 2023 | -3.08x | CN¥-347.81 Million | CN¥112.82 Million | CN¥391.35 Million | ▼ -494.4% |
| 2022 | 0.78x | CN¥2.00 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -2.5% |
| 2021 | 0.80x | CN¥1.50 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▼ -16.4% |
| 2020 | 0.96x | CN¥2.53 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▲ +283.1% |
| 2019 | -0.52x | CN¥-11.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +76.9% |
| 2018 | -2.27x | CN¥-22.84 Million | CN¥10.07 Million | CN¥32.90 Million | — |